javeri fiscal logo
Home SiteMap ContactUs
javeri fiscal services Ltd
IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Speciality Medicines Ltd.
Issue Open Date 20-Mar-26  
Issue Closing Date 24-Mar-26  
Application Money 100  
Allotment Money  
Price Band 117 - 124  
Minimium Application No. 2000  
Issue Size (Shares) 2350000  
Market Lot 1.00  
Objective
1. Setting up of Research and Development (R&D) Centre at Revenue City Survey No. RV1/NA/61/1/50, Moje: Manda, Tal. Umargam, Dist. Valsad, Gujarat;2. Product Registration in International Markets and Product Development for sale in international markets.3. Funding for Marketing and Promotional Activities.4. To Meet Working Capital Requirements; and5. General Corporate Purpose.
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   1239000   2194000   1.77  
Qualified Institutional Buyers   21000   2021000   96.24  
Retail Individual Investors   1090000   922000   0.85  
Business Description
Our company is engaged in marketing & distribution of finished formulations of Specialty pharmaceuticals - high-cost oral or injectable medications used to treat complex chronic conditions in Domestic as well as International Market. Having cultivated strong a
more...
Promoter's Holding
Total Share Capital   4035500  
Offered to Public   2350000  
Promoter's Holding (Pre-Issue)   62.16  
Promoter's Holding (Post-Issue)   43.43  
Address
913
One World West
S. No. 396
F P 119
Village- Vejalpur
Ahmedabad ,
Gujarat ,
380051
Phone:
Email: investors.grievances@specialitymedicine.com
Website: www.specialitymedicine.com
Registrar
Skyline Financial Services Pvt Ltd
D-153/A
1st Floor
Okhla Industrial Area
Phase - I
New Delhi
Listed at
BSE
Lead Manager
Unistone Capital Pvt Ltd.
Promoters
Parth Goyani
Sumit Goyani
Back Back TopTop
kyc form Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Scores| Policies of JFSL
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE| Rights and obligation| SARAL Form
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.